Austin, Texas-based Emergent Technologies was the founding investor in Pure Protein and its two subsidiaries, Pure Vaccine Solutions and Pure Transplant Solutions. Emergent remains its largest investor. Hildebrand is Pure Protein's chief scientist.
Which leads us back to the history lesson. Pure Protein was among the first spinouts — considered by some to be the first — but others were right there, as well. Hyalose emerged from the research of Paul DeAngelis and Paul Weigel at OU and continues operating today, along with a pair of sister companies, Choncept and Heparinex.
Each was founded with a plan to take what was created in a laboratory in Oklahoma and make it commercially available in clinics and hospitals everywhere.
“I think if you are doing research at a medical center, you should envision that research getting out and touching someone,” Hildebrand said. “How are you going to do that? You have to have a company.”
His company is Pure Protein. And it's living history for Oklahoma.
Jim Stafford is communications specialist with i2E Inc. in Oklahoma City.